Works matching AU Burges, Alexander


Results: 73
    1
    2
    3
    4
    5
    6

    Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 11, p. 8719, doi. 10.1007/s00432-023-04708-z
    By:
    • Reichenbach, Juliane;
    • Fraungruber, Patricia;
    • Mayr, Doris;
    • Buschmann, Christina;
    • Kraus, Fabian B. T.;
    • Topalov, Nicole Elisabeth;
    • Chelariu-Raicu, Anca;
    • Kolben, Thomas;
    • Burges, Alexander;
    • Mahner, Sven;
    • Kessler, Mirjana;
    • Jeschke, Udo;
    • Czogalla, Bastian;
    • Trillsch, Fabian
    Publication type:
    Article
    7

    High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 4293, doi. 10.1007/s00432-022-04271-z
    By:
    • Beyer, Susanne;
    • Müller, Lena;
    • Mitter, Sophie;
    • Keilmann, Lucia;
    • Meister, Sarah;
    • Buschmann, Christina;
    • Kraus, Fabian;
    • Topalov, Nicole E.;
    • Czogalla, Bastian;
    • Trillsch, Fabian;
    • Burges, Alexander;
    • Mahner, Sven;
    • Schmoeckel, Elisa;
    • Löb, Sanja;
    • Corradini, Stefanie;
    • Kessler, Mirjana;
    • Jeschke, Udo;
    • Kolben, Thomas
    Publication type:
    Article
    8

    Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 12, p. 3323, doi. 10.1007/s00432-022-04098-8
    By:
    • Kolben, Thomas;
    • Müller, Lena;
    • Meister, Sarah;
    • Keilmann, Lucia;
    • Buschmann, Christina;
    • Trillsch, Fabian;
    • Burges, Alexander;
    • Czogalla, Bastian;
    • Mitter, Sophie;
    • Schmoeckel, Elisa;
    • Corradini, Stefanie;
    • Mahner, Sven;
    • Jeschke, Udo;
    • Kessler, Mirjana;
    • Beyer, Susanne
    Publication type:
    Article
    9
    10

    EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 10, p. 2519, doi. 10.1007/s00432-019-03017-8
    By:
    • Czogalla, Bastian;
    • Kuhn, Christina;
    • Heublein, Sabine;
    • Schmöckel, Elisa;
    • Mayr, Doris;
    • Kolben, Thomas;
    • Trillsch, Fabian;
    • Burges, Alexander;
    • Mahner, Sven;
    • Jeschke, Udo;
    • Hester, Anna
    Publication type:
    Article
    11
    12
    13

    Cytoplasmic VDR expression as an independent risk factor for ovarian cancer.

    Published in:
    Histochemistry & Cell Biology, 2020, v. 154, n. 4, p. 421, doi. 10.1007/s00418-020-01894-6
    By:
    • Czogalla, Bastian;
    • Deuster, Eileen;
    • Liao, Yue;
    • Mayr, Doris;
    • Schmoeckel, Elisa;
    • Sattler, Cornelia;
    • Kolben, Thomas;
    • Hester, Anna;
    • Fürst, Sophie;
    • Burges, Alexander;
    • Mahner, Sven;
    • Jeschke, Udo;
    • Trillsch, Fabian
    Publication type:
    Article
    14

    Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells.

    Published in:
    Cellular Oncology (2211-3428), 2022, v. 45, n. 6, p. 1171, doi. 10.1007/s13402-022-00708-2
    By:
    • Kolben, Thomas;
    • Mannewitz, Mareike;
    • Perleberg, Carolin;
    • Schnell, Konstantin;
    • Anz, David;
    • Hahn, Laura;
    • Meister, Sarah;
    • Schmoeckel, Elisa;
    • Burges, Alexander;
    • Czogalla, Bastian;
    • Hester, Anna;
    • Mahner, Sven;
    • Kessler, Mirjana;
    • Jeschke, Udo;
    • Corradini, Stefanie;
    • Trillsch, Fabian;
    • Beyer, Susanne
    Publication type:
    Article
    15
    16
    17
    18
    19

    The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial.

    Published in:
    International Journal of Cancer, 2010, v. 127, n. 9, p. 2209, doi. 10.1002/ijc.25423
    By:
    • Heiss, Markus M.;
    • Murawa, Pawel;
    • Koralewski, Piotr;
    • Kutarska, Elzbieta;
    • Kolesnik, Olena O.;
    • Ivanchenko, Vladimir V.;
    • Dudnichenko, Alexander S.;
    • Aleknaviciene, Birute;
    • Razbadauskas, Arturas;
    • Gore, Martin;
    • Ganea-Motan, Elena;
    • Ciuleanu, Tudor;
    • Wimberger, Pauline;
    • Schmittel, Alexander;
    • Schmalfeldt, Barbara;
    • Burges, Alexander;
    • Bokemeyer, Carsten;
    • Lindhofer, Horst;
    • Lahr, Angelika;
    • Parsons, Simon L.
    Publication type:
    Article
    20

    Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).

    Published in:
    PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0186043
    By:
    • Harter, Philipp;
    • Hauke, Jan;
    • Heitz, Florian;
    • Reuss, Alexander;
    • Kommoss, Stefan;
    • Marmé, Frederik;
    • Heimbach, André;
    • Prieske, Katharina;
    • Richters, Lisa;
    • Burges, Alexander;
    • Neidhardt, Guido;
    • de Gregorio, Nikolaus;
    • El-Balat, Ahmed;
    • Hilpert, Felix;
    • Meier, Werner;
    • Kimmig, Rainer;
    • Kast, Karin;
    • Sehouli, Jalid;
    • Baumann, Klaus;
    • Jackisch, Christian
    Publication type:
    Article
    21

    Ovarialkarzinom - Diagnostik und Therapie.

    Published in:
    Deutsches Ärzteblatt International, 2012, v. 109, n. 11, p. 208, doi. 10.3238/arztebl.2012.0208a
    By:
    • Burges, Alexander;
    • Schmalfeldt, Barbara
    Publication type:
    Article
    22

    Ovarian Cancer.

    Published in:
    Deutsches Ärzteblatt International, 2011, v. 108, n. 38, p. 635
    By:
    • Burges, Alexander;
    • Schmalfeldt, Barbara
    Publication type:
    Article
    23

    Ovarian Cancer: Diagnosis and Treatment.

    Published in:
    Deutsches Ärzteblatt International, 2011, v. 108, n. 38, p. 635, doi. 10.3238/arztebl.2011.0635
    By:
    • Burges, Alexander;
    • Schmalfeldt, Barbara
    Publication type:
    Article
    24
    25

    Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway.

    Published in:
    Biomedicines, 2021, v. 9, n. 7, p. 706, doi. 10.3390/biomedicines9070706
    By:
    • Liao, Yue;
    • Badmann, Susann;
    • Kaltofen, Till;
    • Mayr, Doris;
    • Schmoeckel, Elisa;
    • Deuster, Eileen;
    • Mannewitz, Mareike;
    • Landgrebe, Sarah;
    • Kolben, Thomas;
    • Hester, Anna;
    • Beyer, Susanne;
    • Burges, Alexander;
    • Mahner, Sven;
    • Jeschke, Udo;
    • Trillsch, Fabian;
    • Czogalla, Bastian
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    Extracapsular Lymph Node Involvement in Ovarian Carcinoma.

    Published in:
    Cancers, 2019, v. 11, n. 7, p. 924, doi. 10.3390/cancers11070924
    By:
    • Heublein, Sabine;
    • Schulz, Heiko;
    • Marmé, Frederik;
    • Angele, Martin;
    • Czogalla, Bastian;
    • Burges, Alexander;
    • Mahner, Sven;
    • Mayr, Doris;
    • Jeschke, Udo;
    • Schmoeckel, Elisa
    Publication type:
    Article
    32
    33
    34
    35

    Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in Germany.

    Published in:
    Archives of Gynecology & Obstetrics, 2023, v. 307, n. 1, p. 129, doi. 10.1007/s00404-022-06730-x
    By:
    • Keilmann, Lucia;
    • Beyer, Susanne;
    • Meister, Sarah;
    • Jegen, Magdalena;
    • Buschmann, Christina;
    • Schröder, Lennard;
    • Keckstein, Simon;
    • Jeschke, Udo;
    • Burges, Alexander;
    • Mahner, Sven;
    • Trillsch, Fabian;
    • Kost, Bernd;
    • Kolben, Thomas
    Publication type:
    Article
    36

    Galectin-8 and -9 as prognostic factors for cervical cancer.

    Published in:
    Archives of Gynecology & Obstetrics, 2022, v. 306, n. 4, p. 1211, doi. 10.1007/s00404-022-06449-9
    By:
    • Beyer, Susanne;
    • Wehrmann, Maya;
    • Meister, Sarah;
    • Kolben, Theresa M.;
    • Trillsch, Fabian;
    • Burges, Alexander;
    • Czogalla, Bastian;
    • Schmoeckel, Elisa;
    • Mahner, Sven;
    • Jeschke, Udo;
    • Kolben, Thomas
    Publication type:
    Article
    37

    The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer.

    Published in:
    Archives of Gynecology & Obstetrics, 2022, v. 305, n. 6, p. 1559, doi. 10.1007/s00404-021-06262-w
    By:
    • Chen, Fangfang;
    • Kolben, Thomas;
    • Meister, Sarah;
    • Czogalla, Bastian;
    • Kolben, Theresa M.;
    • Hester, Anna;
    • Burges, Alexander;
    • Trillsch, Fabian;
    • Schmoeckel, Elisa;
    • Mayr, Doris;
    • Mayerhofer, Artur;
    • Mahner, Sven;
    • Jeschke, Udo;
    • Beyer, Susanne
    Publication type:
    Article
    38
    39

    The effect of fertility-sparing surgery on sexuality and global quality of life in women with malignant ovarian germ cell and sex cord stromal tumors: an analysis of the CORSETT database of the AGO study group.

    Published in:
    2021
    By:
    • Hasenburg, Annette;
    • Plett, Hellmut;
    • Krämer, Bernhard;
    • Braicu, Elena;
    • Czogalla, Bastian;
    • Bossart, Michaela;
    • Singer, Susanne;
    • Mayr, Doris;
    • Staebler, Annette;
    • du Bois, Andreas;
    • Kommoss, Stefan;
    • Link, Theresa;
    • Burges, Alexander;
    • Heitz, Florian;
    • Keul, Jacqueline;
    • Trillsch, Fabian;
    • Harter, Philipp;
    • Wimberger, Pauline;
    • Buderath, Paul;
    • Klar, Maximilian
    Publication type:
    journal article
    40

    NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.

    Published in:
    Archives of Gynecology & Obstetrics, 2021, v. 303, n. 5, p. 1331, doi. 10.1007/s00404-020-05881-z
    By:
    • Sultova, Elena;
    • Westphalen, C. Benedikt;
    • Jung, Andreas;
    • Kumbrink, Joerg;
    • Kirchner, Thomas;
    • Mayr, Doris;
    • Rudelius, Martina;
    • Ormanns, Steffen;
    • Heinemann, Volker;
    • Metzeler, Klaus H.;
    • Greif, Philipp A.;
    • Burges, Alexander;
    • Trillsch, Fabian;
    • Mahner, Sven;
    • Harbeck, Nadia;
    • Wuerstlein, Rachel
    Publication type:
    Article
    41

    Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study Group.

    Published in:
    2020
    By:
    • Canzler, Ulrich;
    • Lück, Hans-Joachim;
    • Neuser, Petra;
    • Sehouli, Jalid;
    • Burges, Alexander;
    • Harter, Philipp;
    • Schmalfeldt, Barbara;
    • Aminossadati, Behnaz;
    • Mahner, Sven;
    • Kommoss, Stefan;
    • Wimberger, Pauline;
    • Pfisterer, Jacobus;
    • de Gregorio, Nikolaus;
    • Hasenburg, Annette;
    • Gropp-Meier, Martina;
    • El-Balat, Ahmed;
    • Jackisch, Christian;
    • du Bois, Andreas;
    • Meier, Werner;
    • Wagner, Uwe
    Publication type:
    journal article
    42

    What is the evidence for lymphadenectomy in presumed early ovarian cancer?

    Published in:
    2019
    By:
    • Schmalfeldt, Barbara;
    • Brambs, Christine;
    • Burges, Alexander;
    • El-Balat, Ahmed;
    • Emons, Günter;
    • Fink, Daniel;
    • Fotopoulou, Christina;
    • Gropp-Meier, Martina;
    • Hanker, Lars-Christian;
    • Harter, Philipp;
    • Hasenburg, Annette;
    • Hauptmann, Steffen;
    • Hilpert, Felix;
    • Kimmig, Rainer;
    • Kommoss, Stefan;
    • Kurzeder, Christian;
    • Mahner, Sven;
    • Marmé, Frederik;
    • Mayr, Doris;
    • Meier, Werner
    Publication type:
    journal article
    43
    44

    The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients.

    Published in:
    British Journal of Clinical Pharmacology, 2015, v. 80, n. 5, p. 1139, doi. 10.1111/bcp.12688
    By:
    • Bachmann, Hagen Sjard;
    • Meier, Werner;
    • Bois, Andreas;
    • Kimmig, Rainer;
    • Kuhlmann, Jan Dominik;
    • Siffert, Winfried;
    • Sehouli, Jalid;
    • Wollschlaeger, Kerstin;
    • Huober, Jens;
    • Hillemanns, Peter;
    • Burges, Alexander;
    • Schmalfeldt, Barbara;
    • Aminossadati, Behnaz;
    • Wimberger, Pauline
    Publication type:
    Article
    45
    46

    Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer.

    Published in:
    International Journal of Cancer, 2020, v. 146, n. 2, p. 439, doi. 10.1002/ijc.32606
    By:
    • Ray‐Coquard, Isabelle;
    • Cibula, David;
    • Mirza, Mansoor R.;
    • Reuss, Alexander;
    • Ricci, Caterina;
    • Colombo, Nicoletta;
    • Koch, Horst;
    • Goffin, Frédéric;
    • González‐Martin, Antonio;
    • Ottevanger, Petronella B.;
    • Baumann, Klaus;
    • Bjørge, Line;
    • Lesoin, Anne;
    • Burges, Alexander;
    • Rosenberg, Per;
    • Gropp‐Meier, Martina;
    • Harrela, Maija;
    • Harter, Philipp;
    • Frenel, Jean‐Sébastien;
    • Minarik, Tomas
    Publication type:
    Article
    47
    48

    Human epididymis protein 4 (HE4) in benign and malignant diseases.

    Published in:
    Clinical Chemistry & Laboratory Medicine, 2012, v. 50, n. 12, p. 2181, doi. 10.1515/cclm-2012-0097
    By:
    • Hertlein, Linda;
    • Stieber, Petra;
    • Kirschenhofer, Angela;
    • Fürst, Sophie;
    • Mayr, Doris;
    • Hofmann, Karin;
    • Krocker, Katja;
    • Nagel, Dorothea;
    • Lenhard, Miriam;
    • Burges, Alexander
    Publication type:
    Article
    49
    50

    Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors.

    Published in:
    Clinical Chemistry & Laboratory Medicine, 2009, v. 47, n. 5, p. 537, doi. 10.1515/CCLM.2009.134
    By:
    • Lenhard, Miriam S.;
    • Nehring, Stefanie;
    • Nagel, Dorothea;
    • Mayr, Doris;
    • Kirschenhofer, Angela;
    • Hertlein, Linda;
    • Friese, Klaus;
    • Stieber, Petra;
    • Burges, Alexander
    Publication type:
    Article